JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Short Interest Update

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) saw a significant drop in short interest during the month of July. As of July 15th, there was short interest totalling 405,000 shares, a drop of 21.8% from the June 30th total of 517,600 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.

JCR Pharmaceuticals Price Performance

JCRRF stock remained flat at $4.30 during mid-day trading on Tuesday. The stock’s fifty day moving average is $5.11 and its 200 day moving average is $6.11. JCR Pharmaceuticals has a fifty-two week low of $4.30 and a fifty-two week high of $4.30.

JCR Pharmaceuticals Company Profile

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.